Menu
Back to User profile » Dr Yayun Liang
Papers published by Dr Yayun Liang:
APR-246 alone and in combination with a phosphatidylserine-targeting antibody inhibits lung metastasis of human triple-negative breast cancer cells in nude mice
Liang Y, Besch-Williford C, Cook MT, Belenchia A, Brekken RA, Hyder SM
Breast Cancer: Targets and Therapy 2019, 11:249-259
Published Date: 31 July 2019
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
Liang Y, Mafuvadze B, Besch-Williford C, Hyder SM
Breast Cancer: Targets and Therapy 2018, 10:53-67
Published Date: 22 March 2018
Cholesterol biosynthesis inhibitor RO 48-8071 reduces progesterone receptor expression and inhibits progestin-dependent stem cell-like cell growth in hormone-dependent human breast cancer cells
Liang Y, Goyette S, Hyder SM
Breast Cancer: Targets and Therapy 2017, 9:487-494
Published Date: 7 July 2017
Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro
Goyette S, Liang Y, Mafuvadze B, Cook MT, Munir M, Hyder SM
Breast Cancer: Targets and Therapy 2017, 9:347-357
Published Date: 19 May 2017
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
Cook MT, Liang Y, Besch-Williford C, Hyder SM
Breast Cancer: Targets and Therapy 2017, 9:9-19
Published Date: 23 December 2016
Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells
Liang Y, Mafuvadze B, Aebi JD, Hyder SM
OncoTargets and Therapy 2016, 9:3223-3232
Published Date: 30 May 2016